Research published recently in Science as Culture suggests that men are surprisingly positive and open to the concept of having cancer-detecting biosensors implanted within their bodies – effectively making them cyborgs.
Such auto biotechnologies can aid in the treatment or repair of tissue and organs without external human direction or control. They represent version 2.0 of cyborgs as originally invented by Clynes and Kline in the early 1960’s, referred to as the bodily adaptations required by individuals to live in outer space. Since then, science and technology have made giant leaps forward, leading to the innovative concept of ‘everyday cyborgs’, now increasingly forming an integral part of our reality.
Cyborgs are common in science fiction and are traditionally perceived as lacking emotion and human feeling. ‘Everyday cyborgs’ however, are real people who just happen to live with highly sophisticated devices – devices which could save lives.
In the article ‘Cyborgs in the Everyday: Masculinity and Biosensing Prostate Cancer ’ lead author Gill Haddow explores the phenomenon, portraying a new version of cyborg that goes beyond the traditional science-fiction monster stereotype we are used to. Haddow argues that biosensors are the key devices that differentiate a cyborg from default human beings, sensing when cancer tumours, present in organs such as the prostate, will be most vulnerable to radiotherapy.
Investigating opinions on such devices, by interviewing a dozen men recovering from prostate cancer, threw up surprisingly positive and open views. Biosensors were well received and the men interviewed felt that the devices might even be used as a long-term warning system, alerting doctors when a cancer might have returned and potentially delivering drug therapy. As reported by Haddow: “Any possible malfunctioning of the device was a risk worth taking as it was better to be cyborg than a ‘leaker and a bleeder’ – a crude term referring to the spoiled masculine identity that can be caused by prostate cancer”.
The study suggested that having cancer increased the willingness of the individual to try anything, even life as a cyborg. In light of that, the everyday cyborg becomes neither a monster nor a future space-traveller but, in this case, a man sick and vulnerable prepared to fight for his life with an implanted device.
Learn more: Cyborgs in the Everyday: Masculinity and Biosensing Prostate Cancer
The Latest on: Biosensor
via Google News
The Latest on: Biosensor
- PhysIQ Recognized as a 2021 Hottest Health Tech Companyon January 15, 2021 at 12:57 am
The Observer names physIQ as one of the hottest tech companies in the US second straight year for outstanding work amid the global COVID-19 pandemic. (Photo: Business Wire) In early 2020, physIQ ...
- Texas A&M students create a rapid COVID-19 test prototype using biosensor technologyon January 14, 2021 at 10:04 pm
News Highlights: Texas A&M students create a rapid COVID-19 test prototype using biosensor technology COLLEGE STATION, Texas (KBTX) - Four Texas A&M ...
- Texas A&M students create rapid COVID-19 test prototype using biosensor technologyon January 14, 2021 at 8:59 pm
COLLEGE STATION, Texas (KBTX) - Four Texas A&M biomedical engineering students teamed up to create a prototype for a rapid COVID-19 test that uses a biosensor. At the outset of the pandemic ...
- One step closer to an at-home, rapid COVID-19 teston January 14, 2021 at 9:48 am
The FINANCIAL -- The lab of César de la Fuente is working on a paper-based biosensor that could provide results in minutes. Clinical trials began Jan. 5. The lab of Penn’s César de la Fuente ...
- PhysIQ Recognized as a 2021 Hottest Health Tech Companyon January 14, 2021 at 6:14 am
The company uses near real time biosensor data combined with platform powered by FDA-cleared AI based analytics and transforms it into personalized patient insights for healthcare providers and ...
- Improved understanding and treatment of inflammatory diseaseson January 13, 2021 at 3:57 am
Over the next four years, the international research project SciFiMed aims to develop a biosensor to help better characterise inflammatory reactions in the body. This visionary project ...
- Glucose Biosensor Market Research, Report, In-depth Insight, Industry Forecast to 2025 Key playerson January 5, 2021 at 10:00 pm
The Glucose Biosensor Market is expected to exceed more than US$ 30.5 Billion by 2024 at a CAGR of 10.29% in the ...
via Bing News